Abstract：Metastasis of tumor cells poses great difficulties for tumor therapy. Tumor microenvironment is a complex and rich multicellular environment for the development of tumors, in which tumor-associated immune cells induce tumor cells to undergo epithelial-mesenchymal transition (EMT) which enhances the invasiveness and motility of tumor cells and prompts tumor cells to metastasize, and tumor cells undergoing EMT secrete cytokines and other substances to reorganize the tumor microenvironment. The interaction between EMT and the tumor microenvironment aggravate tumor invasion and metastasis. This paper collects research literature on tumor microenvironment and EMT of tumor cells from 2015 to 2023, and reviews the role of tumor microenvironment in tumor EMT, providing the basis for research into tumor metastasis mechanism and development of anti-tumor drugs.
[1] BEJARANO L,JORDĀO M J C,JOYCE J A.Therapeutic targeting of the tumor microenvironment[J].Cancer Discov,2021,11(4):933-959. [2] YEUNG K T,YANG J.Epithelial-mesenchymal transition in tumor metastasis[J].Mol Oncol,2017,11(1):28-39. [3] MA T T,MENG X M.TGF-β/Smad and renal fibrosis[J].Adv Exp Med Biol,2019(1165):347-364. [4] ERIN N,GRAHOVAC J,BROZOVIC A,et al.Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance[J/OL].Drug Resist Updat,2020,53[2023-09-08].https://doi.org/10.1016/j.drup.2020.100715. [5] HUANG Y H,HONG W Q,WEI X W.The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis[J].J Hematol Oncol,2022,15(1):1-27. [6] ECKERT M A,LWIN T M,CHANG A T,et al.Twist1-induced invadopodia formation promotes tumor metastasis[J].Cancer Cell,2011,19(3):372-386. [7] LEONG H S,ROBERTSON A E,STOLETOV K,et al.Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis[J].Cell Rep,2014,8(5):1558-1570. [8] GARG M.Epithelial-mesenchymal transition-activating transcription factors-multifunctional regulators in cancer[J].World J Stem Cells,2013,5(4):188-195. [9] ROMANO M,FANELLI G,ALBANY C J,et al.Past,present,and future of regulatory T cell therapy in transplantation and autoimmunity[J/OL].Front Immunol,2019,10[2023-09-08].https://doi.org/10.3389/fimmu.2019.00043. [10] LIU J H,LI C X,ZHANG L Y,et al.Association of tumour-associated macrophages with cancer cell EMT,invasion,and metastasis of Kazakh oesophageal squamous cell cancer[J].Diagn Pathol,2019,14(1):1-9. [11] WEI C,YANG C G,WANG S Y,et al.Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis[J].Mol Cancer,2019,18(1):1-23. [12] JIANG Y,HAN Q J,ZHAO H J,et al.Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis[J].J Exp Clin Cancer Res,2021,40(1):1-18. [13] YANG C G,DOU R Z,WEI C,et al.Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis[J].Mol Ther,2021,29(6):2088-2107. [14] RIABOV V,GUDIMA A,WANG N,et al.Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis[J/OL].Front Physiol,2014,5[2023-09-08].https://doi.org/10.3389/fphys.2014.00075. [15] WANG Y H,LI X,ZHANG T C,et al.Neutrophils promote tumor invasion via FAM3C-mediated epithelial-to-mesenchymal transition in gastric cancer[J].Int J Biol Sci,2023,19(5):1352-1368. [16] LI S,CONG X L,GAO H Y,et al.Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells[J/OL].J Exp Clin Cancer Res,2019,38[2023-09-08].https://doi.org/10.1186/s13046-018-1003-0. [17] HU X Y,XIANG F G,FENG Y Y,et al.Neutrophils promote tumor progression in oral squamous cell carcinoma by regulating EMT and JAK2/STAT3 signaling through chemerin[J/OL].Front Oncol,2022,12[2023-09-08].https://doi.org/10.3389/fonc.2022.812044. [18] TAKI M,ABIKO K,UKITA M,et al.Tumor immune microenvironment during epithelial-mesenchymal transition[J].Clin Cancer Res,2021,27(17):4669-4679. [19] GOULET C R,CHAMPAGNE A,BERNARD G,et al.Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling[J/OL].BMC Cancer,2019,19[2023-09-08].https://doi.org/10.1186/s12885-019-5353-6. [20] WANG H B,WEI H,WANG J S,et al.MicroRNA-181d-5p-containing exosomes derived from CAFs promote EMT by regulating CDX2/HOXA5 in breast cancer[J].Mol Ther-Nucl Acids,2020,19:654-667. [21] HU J L,WANG W,LAN X L,et al.CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer[J/OL].Mol Cancer,2019,18[2023-09-08].https://doi.org/10.1186/s12943-019-1019-x. [22] CHAE Y K,CHANG S,KO T,et al.Epithelial-mesenchymal transition(EMT)signature is inversely associated with T-cell infiltration in non-small cell lung cancer(NSCLC)[J/OL].Sci Rep,2018,8[2023-09-08].https://doi.org/10.1038/s41598-018-21061-1. [23] XIE F,ZHOU X Y,SU P,et al.Breast cancer cell-derived extracellular vesicles promote CD8+T cell exhaustion via TGF-β type II receptor signaling[J/OL].Nat Commun,2022,13(1)[2023-09-08].https://doi.org/10.1038/s41467-022-31250-2. [24] GOEBEL L,GRAGE-GRIEBENOW E,GORYS A,et al.CD4+T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells-novel implications of CD4+T cells in pancreatic cancer development[J/OL].Oncoimmunology,2015,4(4)[2023-09-08].http://dx.doi.org/10.1080/2162402X.2014.1000083. [25] GARCÍA-CUELLAR C M,SANTIBÁÑEZ-ANDRADE M,CHIRINO Y I,et al.Particulate matter(PM10)promotes cell invasion through epithelial-mesenchymal transition(EMT)by TGF-β activation in A549 lung cells[J/OL].Int J Mol Sci,2021,22(23)[2023-09-08].https://doi.org/10.3390/ijms222312632. [26] LI Y X,WANG P,YE D M,et al.IGHG1 induces EMT in gastric cancer cells by regulating TGF-β/Smad3 signaling pathway[J].J Cancer,2021,12(12):3458-3467. [27] WANG G,ZHOU X W,GUO Z L,et al.The anti-fibrosis drug pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β[J].Cancer Biol Ther,2022,23(1):150-162. [28] HUANG M L,FU M R,WANG J,et al.TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion,metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α[J/OL].Biochem Pharmacol,2021,188[2023-09-08].https://doi.org/10.1016/j.bcp.2021.114527. [29] OSHIMORI N,ORISTIAN D,FUCHS E.TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma[J].Cell,2015,160(5):963-976. [30] CHEN L,LIN G X,CHEN K H,et al.VEGF promotes migration and invasion by regulating EMT and MMPs in nasopharyngeal carcinoma[J].J Cancer,2020,11(24):7291-7301. [31] YANG Y L,CAO Y H.The impact of VEGF on cancer metastasis and systemic disease[J].Semin Cancer Biol,2022,86:251-261. [32] CHEN Y,ZHANG L,LIU W X,et al.VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer[J/OL].Cell Mol Biol Lett,2018,23[2023-09-08].https://doi.org/10.1186/s11658-017-0058-9. [33] LIU L,YE Y,ZHU X M.MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway[J/OL].Biomed Pharmacother,2019,117[2023-09-08].https://doi.org/10.1016/j.biopha.2019.109096. [34] WU H T,LIN J,LIU Y E,et al.Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway[J/OL].Phytomedicine,2021,81[2023-09-08].https://doi.org/10.1016/j.phymed.2020.153437. [35] HWANG K E,KIM H J,SONG I S,et al.Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer[J].Int J Med Sci,2021,18(3):715-726.
